The Pathway to a Universal Influenza Vaccine In 2018, the National Institute of Allergy and Infectious Diseases (NIAID) unveiled its strategic plan for developing a

The initiation of the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program was announced by the National Institute of Allergy and Infectious Diseases (NIAID), part of